Table 4.

Recommendation Regarding Restarting Antiplatelet Agents According to the Medicine Classification

Patents	Antiplatelet agents	Recommendation	Level of recommendation	Level of evidence
Antiplatelet use for secondary prophylaxis of known cardiovascular disease	Aspirin	Restart after endoscopic hemostasis	Strong	High
	Other agents (e.g. P2Y12 receptor inhibitor)	Restart after endoscopic hemostasis	Strong	Low
	Dual antiplatelet therapy (DAPT)	Restart aspirin after endoscopic hemostasis. Early cardiology consultation for resuming the second antiplatelet agent.	Strong	Low